112 related articles for article (PubMed ID: 20135636)
1. Protease inhibitors: a panacea?
Haq SK; Rabbani G; Ahmad E; Atif SM; Khan RH
J Biochem Mol Toxicol; 2010; 24(4):270-7. PubMed ID: 20135636
[TBL] [Abstract][Full Text] [Related]
2. Proteases and protease inhibitors.
Van Noorden CJ
Acta Histochem; 1997 Aug; 99(3):245-7. PubMed ID: 9381907
[No Abstract] [Full Text] [Related]
3. [Protease inhibitors are effective not only in AIDS].
Wehr A
Dtsch Med Wochenschr; 1998 Jan; 123(1-2):A9-10. PubMed ID: 9465846
[No Abstract] [Full Text] [Related]
4. Matrix metalloproteinases in asthma and COPD.
Demedts IK; Brusselle GG; Bracke KR; Vermaelen KY; Pauwels RA
Curr Opin Pharmacol; 2005 Jun; 5(3):257-63. PubMed ID: 15907912
[TBL] [Abstract][Full Text] [Related]
5. Secretases as therapeutic targets for Alzheimer's disease.
Woo HN; Baik SH; Park JS; Gwon AR; Yang S; Yun YK; Jo DG
Biochem Biophys Res Commun; 2011 Jan; 404(1):10-5. PubMed ID: 21130746
[TBL] [Abstract][Full Text] [Related]
6. [Secretases as therapeutic targets for the treatment of Alzheimer's disease].
Dejaegere T; de Strooper B
Verh K Acad Geneeskd Belg; 2004; 66(1):29-58; discussion 58-9. PubMed ID: 15074081
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: from pathology to therapeutic approaches.
Jakob-Roetne R; Jacobsen H
Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
[TBL] [Abstract][Full Text] [Related]
8. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH
Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541
[TBL] [Abstract][Full Text] [Related]
9. Biological activity and clinical implications of the matrix metalloproteinases.
Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
[TBL] [Abstract][Full Text] [Related]
10. Secretase inhibitors and modulators for Alzheimer's disease treatment.
Tomita T
Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
Kreft AF; Martone R; Porte A
J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
[No Abstract] [Full Text] [Related]
12. [Protease inhibitors].
Hamada Y; Kiso Y
Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1702-7. PubMed ID: 18051403
[No Abstract] [Full Text] [Related]
13. Recent advances in the development of gamma-secretase inhibitors.
Josien H
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):513-25. PubMed ID: 12197309
[TBL] [Abstract][Full Text] [Related]
14. The impact of HIV-protease inhibitors on opportunistic parasites.
Pozio E; Morales MA
Trends Parasitol; 2005 Feb; 21(2):58-63. PubMed ID: 15664527
[TBL] [Abstract][Full Text] [Related]
15. [HIV protease inhibitors (new possibilities in the treatment of HIV infection and AIDS)].
Bálint GS
Orv Hetil; 1998 Jun; 139(24):1471-4. PubMed ID: 9658865
[TBL] [Abstract][Full Text] [Related]
16. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
Pollack SJ; Lewis H
Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
[TBL] [Abstract][Full Text] [Related]
17. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease.
Silvestri R
Med Res Rev; 2009 Mar; 29(2):295-338. PubMed ID: 18651582
[TBL] [Abstract][Full Text] [Related]
18. Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease.
Ducruet AP; Vogt A; Wipf P; Lazo JS
Annu Rev Pharmacol Toxicol; 2005; 45():725-50. PubMed ID: 15822194
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the CDC25 phosphatases.
Prevost GP; Brezak MC; Goubin F; Mondesert O; Galcera MO; Quaranta M; Alby F; Lavergne O; Ducommun B
Prog Cell Cycle Res; 2003; 5():225-34. PubMed ID: 14593717
[TBL] [Abstract][Full Text] [Related]
20. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
